Our study unveils novel cellular and molecular mechanisms of tumor-derived extracellular vesicles in regulating CD4+ effector T cell function and pinpoint TRAPs as a therapeutic target for cancer immunotherapy. The gene discussed is CD4; the disease is neoplasm.